Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1988-7-14
|
| pubmed:abstractText |
Eighty-seven postmenopausal patients have been randomised to receive either radiotherapy or Nolvadex (tamoxifen) as first line treatment for locally advanced (stage III) breast cancer. After a median follow-up of two years no significant differences have been found in the rate of progression of local disease, the time to development of overt metastases or survival.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0748-7983
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
14
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
235-40
|
| pubmed:dateRevised |
2007-7-2
|
| pubmed:meshHeading |
pubmed-meshheading:3371476-Breast Neoplasms,
pubmed-meshheading:3371476-Combined Modality Therapy,
pubmed-meshheading:3371476-Female,
pubmed-meshheading:3371476-Humans,
pubmed-meshheading:3371476-Neoplasm Metastasis,
pubmed-meshheading:3371476-Neoplasm Staging,
pubmed-meshheading:3371476-Random Allocation,
pubmed-meshheading:3371476-Receptors, Estrogen,
pubmed-meshheading:3371476-Tamoxifen,
pubmed-meshheading:3371476-Ulcer
|
| pubmed:year |
1988
|
| pubmed:articleTitle |
The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer.
|
| pubmed:affiliation |
City Hospital, Nottingham, U.K.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|